These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 12635559)
21. [Attributable risk of co-morbid substance use disorder in poor observance to pharmacological treatment and the occurrence of relapse in schizophrenia]. Ameller A; Gorwood P Encephale; 2015 Apr; 41(2):174-83. PubMed ID: 25838239 [TBL] [Abstract][Full Text] [Related]
22. What is the relationship between schizophrenia and substance abuse? Green AI Harv Ment Health Lett; 2000 Oct; 17(4):8. PubMed ID: 11015759 [No Abstract] [Full Text] [Related]
23. Medication noncompliance and substance abuse among patients with schizophrenia. Owen RR; Fischer EP; Booth BM; Cuffel BJ Psychiatr Serv; 1996 Aug; 47(8):853-8. PubMed ID: 8837158 [TBL] [Abstract][Full Text] [Related]
24. Pharmacotherapy for schizophrenia and co-occurring substance use disorders. Noordsy DL; Green AI Curr Psychiatry Rep; 2003 Oct; 5(5):340-6. PubMed ID: 13678553 [TBL] [Abstract][Full Text] [Related]
31. Comorbid substance use disorder in schizophrenia: a selective overview of neurobiological and cognitive underpinnings. Thoma P; Daum I Psychiatry Clin Neurosci; 2013 Sep; 67(6):367-83. PubMed ID: 23890122 [TBL] [Abstract][Full Text] [Related]
32. Randomized controlled trial of motivational interviewing, cognitive behavior therapy, and family intervention for patients with comorbid schizophrenia and substance use disorders. Barrowclough C; Haddock G; Tarrier N; Lewis SW; Moring J; O'Brien R; Schofield N; McGovern J Am J Psychiatry; 2001 Oct; 158(10):1706-13. PubMed ID: 11579006 [TBL] [Abstract][Full Text] [Related]
33. An RCT of adherence therapy for people with schizophrenia in Chiang Mai, Thailand. Maneesakorn S; Robson D; Gournay K; Gray R J Clin Nurs; 2007 Jul; 16(7):1302-12. PubMed ID: 17584349 [TBL] [Abstract][Full Text] [Related]
34. Medical psychotherapy of schizophrenia--a dynamic/supportive approach. Corradi RB J Am Acad Psychoanal Dyn Psychiatry; 2004; 32(4):633-43. PubMed ID: 15585422 [TBL] [Abstract][Full Text] [Related]
35. Treatment of substance abuse in severely mentally ill patients. Drake RE; Bartels SJ; Teague GB; Noordsy DL; Clark RE J Nerv Ment Dis; 1993 Oct; 181(10):606-11. PubMed ID: 8105026 [TBL] [Abstract][Full Text] [Related]
36. Clozapine use and relapses of substance use disorder among patients with co-occurring schizophrenia and substance use disorders. Brunette MF; Drake RE; Xie H; McHugo GJ; Green AI Schizophr Bull; 2006 Oct; 32(4):637-43. PubMed ID: 16782758 [TBL] [Abstract][Full Text] [Related]
37. Substance abuse and schizophrenia: impediments to optimal care. Salloum IM; Moss HB; Daley DC Am J Drug Alcohol Abuse; 1991 Sep; 17(3):321-36. PubMed ID: 1928026 [TBL] [Abstract][Full Text] [Related]
38. Group treatment for substance abuse in schizophrenia. Addington J; el-Guebaly N Can J Psychiatry; 1998 Oct; 43(8):843-5. PubMed ID: 9806092 [TBL] [Abstract][Full Text] [Related]
39. Pharmacotherapy for schizophrenia and co-occurring substance use disorders. Green AI Neurotox Res; 2007 Jan; 11(1):33-40. PubMed ID: 17449446 [TBL] [Abstract][Full Text] [Related]
40. Effects of substance abuse on hallucination rates and treatment responses in chronic psychiatric patients. Sokolski KN; Cummings JL; Abrams BI; DeMet EM; Katz LS; Costa JF J Clin Psychiatry; 1994 Sep; 55(9):380-7. PubMed ID: 7929017 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]